Jeffrey S Montgomery, MD, MHSA, FACS
Clinical Professor of Urology and Associate Chair
Department of Urology
Finance
[email protected]

Available to mentor

Jeffrey S Montgomery, MD, MHSA, FACS
Clinical Professor
  • Center Memberships
  • Recent Publications
  • Center Memberships
    • Center Member
      Rogel Cancer Center
    Recent Publications See All Publications
    • Journal Article
      Social Vulnerability and Receipt of Neoadjuvant Chemotherapy in Patients Undergoing Radical Cystectomy for Bladder Cancer.
      Sekar RR, Irani S, Maganty A, Montgomery JS, Herrel LA. Urology, 2024 Sep; 191: 79 - 84. DOI:10.1016/j.urology.2024.05.006
      PMID: 38763474
    • Journal Article
      "Prostatectomy after gender-affirming vaginoplasty for a transgender woman with prostate cancer".
      Blasdel G, Borah L, Navarrete R, Howland R, Kuzon WM, Montgomery JS. Urol Case Rep, 2024 Sep; 56: 102819 DOI:10.1016/j.eucr.2024.102819
      PMID: 39220296
    • Journal Article
      Efficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Phase 3 Trial.
      Narayan VM, Boorjian SA, Alemozaffar M, Konety BR, Shore ND, Gomella LG, Kamat AM, Bivalacqua TJ, Montgomery JS, Lerner SP, Busby JE, Poch M, Crispen PL, Steinberg GD, Schuckman AK, Downs TM, Mashni J, Lane BR, Guzzo TJ, Bratslavsky G, Karsh LI, Woods ME, Brown G, Canter D, Luchey A, Lotan Y, Inman BA, Williams MB, Cookson MS, Chang SS, Sankin AI, O'Donnell MA, Sawutz D, Philipson R, Parker NR, Yla-Herttuala S, Rehm D, Jakobsen JS, Juul K, Dinney CPN. J Urol, 2024 Jul; 212 (1): 74 - 86. DOI:10.1097/JU.0000000000004020
      PMID: 38704840
    • Journal Article
      Transperineal Versus Transrectal Magnetic Resonance Imaging-targeted and Systematic Prostate Biopsy to Prevent Infectious Complications: The PREVENT Randomized Trial.
      Hu JC, Assel M, Allaf ME, Ehdaie B, Vickers AJ, Cohen AJ, Ristau BT, Green DA, Han M, Rezaee ME, Pavlovich CP, Montgomery JS, Kowalczyk KJ, Ross AE, Kundu SD, Patel HD, Wang GJ, Graham JN, Shoag JE, Ghazi A, Singla N, Gorin MA, Schaeffer AJ, Schaeffer EM. Eur Urol, 2024 Jul; 86 (1): 61 - 68. DOI:10.1016/j.eururo.2023.12.015
      PMID: 38212178
    • Journal Article
      Perioperative Blood Transfusion Is Associated with Worse Survival in Patients Undergoing Radical Cystectomy after Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
      Ladner T, Black AJ, Zargar H, Wright JL, Thorpe AC, Morgan TM, Holzbeierlein JM, Cookson MS, Jacobsen N-E, Fairey AS, Dinney CPN, Mir MC, Krabbe L-M, Montgomery JS, Vasdev N, Yu EY, Xylinas E, Stephenson AJ, Shah JB, Daneshmand S, Zargar-Shoshtari K, Spiess PE, Mertens LS, van Rhijn BWG, Grivas P, Kassouf W, Dall’Era MA, Sridhar SS, McGrath JS, Aning J, Shariat SF, Bivalacqua TJ, North SA, Barocas DA, Lotan Y, Black PC. Société Internationale d’Urologie Journal, 5 (3): 202 - 213. DOI:10.3390/siuj5030031
    • Journal Article
      Neoadjuvant platinum-based chemotherapy and lymphadenectomy for penile cancer: an international, multi-institutional, real-world study.
      Rose KM, Pham R, Zacharias NM, Ionescu F, Paravathaneni M, Marchetti KA, Sanchez D, Mustasam A, Sandstrom R, Vikram R, Dhillon J, Rao P, Schneider A, Pagliaro L, Alifrangis C, Albersen M, Roussel E, Master VA, Nazha B, Hernandez C, Moses KA, Protzel C, Montgomery J, Angel M, Tobias-Machado M, Spiess PE, Pettaway CA, Chahoud J. J Natl Cancer Inst, 2024 Jun 7; 116 (6): 966 - 973. DOI:10.1093/jnci/djae034
      PMID: 38366627
    • Journal Article
      Abstract A009: Integrative drug screening and multi-omic characterization of patient-derived bladder cancer organoids reveals novel molecular correlates of chemotherapy response
      Merrill NM, Kaffenberger SD, Bao L, Vandecan N, Goo LE, Apfel A, Cheng X, Qin Z, Liu C-J, Bankhead A, Wang Y, Kathawate V, Tudrick L, Serhan H, Farah Z, Ellimoottil C, Hafez KS, Herrel LA, Montgomery JS, Morgan TM, Salami SS, Weizer AZ, Ulintz PJ, Day ML, Soellner MB, Palmbos PL, Merajver SD, Udager AM. Clinical Cancer Research, 2024 May 17; 30 (10_Supplement): A009 - A009. DOI:10.1158/1557-3265.bladder24-a009
    • Journal Article
      NCCN Guidelines® Insights: Bladder Cancer, Version 3.2024.
      Flaig TW, Spiess PE, Abern M, Agarwal N, Bangs R, Buyyounouski MK, Chan K, Chang SS, Chang P, Friedlander T, Greenberg RE, Guru KA, Herr HW, Hoffman-Censits J, Kaimakliotis H, Kishan AU, Kundu S, Lele SM, Mamtani R, Mian OY, Michalski J, Montgomery JS, Parikh M, Patterson A, Peyton C, Plimack ER, Preston MA, Richards K, Sexton WJ, Siefker-Radtke AO, Stewart T, Sundi D, Tollefson M, Tward J, Wright JL, Cassara CJ, Gurski LA. J Natl Compr Canc Netw, 2024 May; 22 (4): 216 - 225. DOI:10.6004/jnccn.2024.0024
      PMID: 38754471
    Featured News & Stories
    Health Lab
    Should you get a PSA screening for prostate cancer?
    After a hotly contested study citing a spike in advanced prostate cancer, the discussion over declining use of a preventive test has been renewed.